Idaho Healthcare Hub
SEE OTHER BRANDS

Following health and wellness news from Idaho

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on June 11, 2025

MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline

MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm,” the “Company,” “we” or “us”), a pharmaceutical company specialized in precision-based cannabinoids, today reminded its shareholders that the …

Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board of Directors

Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board of Directors

CROWN POINT, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Neurodon Corp., a leader in the development of endoplasmic reticulum (ER) stress-targeted therapeutics for diabetes and neurodegeneration, welcomes Frederick Beddingfield, III, M.D., Ph.D., a 22-year …

Norton Children’s announces new pediatric care campus, second dedicated pediatric hospital

Norton Children’s announces new pediatric care campus, second dedicated pediatric hospital

LOUISVILLE, Ky., June 11, 2025 (GLOBE NEWSWIRE) -- Norton Children’s, a comprehensive pediatric health care system based in Louisville, plans to build a new pediatric care campus that will include a full-service hospital for children with complex medical …

Psychedelic Science 2025 Unveils Science, Studies & Trials Tracks Showcasing Next Generation in Brain Imaging, Clinical Trials, and Neuroplasticity

Psychedelic Science 2025 Unveils Science, Studies & Trials Tracks Showcasing Next Generation in Brain Imaging, Clinical Trials, and Neuroplasticity

• Sessions cover the latest updates in psychedelic neuroscience, from psilocybin’s effects on brain connectivity to trial design, clinical outcomes for PTSD, depression, addiction, and OCD, and the future of drug development through translational models …

DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025

DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025

Châtillon, France, le 11 juin 2025 DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025 Toutes les résolutions proposées à l’Assemblée Générale ont été adoptées DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock …

AIM ImmunoTech Announces 1-for-100 Reverse Stock Split

AIM ImmunoTech Announces 1-for-100 Reverse Stock Split

OCALA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) (“AIM” or the “Company”) today announced a reverse stock split (“Reverse Stock Split”) of its shares at a ratio of 1-for-100. The Reverse Stock Split …

SRx Health Solutions Announces Management and Board Changes

SRx Health Solutions Announces Management and Board Changes

TAMPA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced the following management team and Board of Directors changes. Lionel Conacher, …

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

BEDFORD, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025

Three of eight evaluable patients with R/R AML responded after cycle 1 in ongoing cohort 8, including 1 patient with ongoing response beyond 6 months Acceptable safety profile across all cohorts, including in cohort 8 with steeper step-up dosing Data …

Karen Ego of Doodle Bugs! Children's Center Highlights the Value of Purposeful Play in HelloNation Magazine

Karen Ego of Doodle Bugs! Children's Center Highlights the Value of Purposeful Play in HelloNation Magazine

VICTOR, N.Y., June 11, 2025 (GLOBE NEWSWIRE) -- How does play prepare young children for lifelong learning? In a featured article in HelloNation Magazine, Karen Ego of Doodle Bugs! Children's Center in Victor, New York, emphasizes that play is far more …

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

WOBURN, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), confirms a disclosure by the Management Board of Biofrontera AG on …

Chiesi Group ingår ett globalt licensavtal med Key2Brain AB för utveckling av terapier som passerar blod-hjärnbarriären för behandling av lysosomala upplagringssjukdomar

Chiesi Group ingår ett globalt licensavtal med Key2Brain AB för utveckling av terapier som passerar blod-hjärnbarriären för behandling av lysosomala upplagringssjukdomar

Samarbetet kommer att utnyttja Key2Brains teknik för att ta fram enzymersättningsbehandlingar som passerar blod-hjärnbarriären för lysosomala upplagringssjukdomar Avtalet bygger på ett partnerskap som inleddes 2022 och stödjer fortsatt utveckling som drivs …

Chiesi Group sigla un accordo di licenza mondiale con Key2Brain AB per promuovere terapie che attraversano la barriera ematoencefalica per le malattie da accumulo lisosomiale

Chiesi Group sigla un accordo di licenza mondiale con Key2Brain AB per promuovere terapie che attraversano la barriera ematoencefalica per le malattie da accumulo lisosomiale

La collaborazione sfrutterà la tecnologia di Key2Brain per sviluppare terapie enzimatiche sostitutive in grado di attraversare la barriera ematoencefalica per le malattie da accumulo lisosomiale L'accordo si basa su una partnership avviata nel 2022, a …

SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide

SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide

IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test (formally …

Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight

Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight

New York, USA, June 11, 2025 (GLOBE NEWSWIRE) -- Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight The electronic health records market is experiencing robust growth, primarily driven by the increasing …

ONWARD Medical Announces Results of its Annual General Meeting of Shareholders

ONWARD Medical Announces Results of its Annual General Meeting of Shareholders

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, The Netherlands, June 11, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical …

AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025

AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025

AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025 NANTES, France, 11 juin 2025, 18 heures 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce l'annulation de la convocation à l'Assemblée Générale mixte …

WellSpan Provider Network expands robust network of care

WellSpan Provider Network expands robust network of care

York, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- WellSpan Health is pleased to announce the expansion of its WellSpan Provider Network (WPN) this summer with key providers and practices across the region joining the network. This ensures convenient access for …

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health …

Centre for Neuro Skills Unveils New Website Design to Better Serve Brain Injury Patients and Their Families

Centre for Neuro Skills Unveils New Website Design to Better Serve Brain Injury Patients and Their Families

BAKERSFIELD, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Centre for Neuro Skills (CNS), a leader in traumatic brain injury and stroke rehabilitation services, today announced the launch of its completely redesigned website at www.neuroskills.com. The …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service